We are live on !
Find out more
Cliff Asness AQR Capital Management
AUM
$287B
Turnover
8.35%
1-Year Est. Return
42.33%
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
This Fund
S&P 500
This Quarter Est. Return
+22.95%
1 Year Est. Return
+42.33%
3 Year Est. Return
+119.89%
5 Year Est. Return
+147.33%
10 Year Est. Return
+543.74%
AUM
$287B
AUM Growth
+$68.5B
(+31%)
Cap. Flow
+$37.5B
Cap. Flow % of AUM
Cap. Flow %
13.08%
Top 10 Holdings %
Top 10 Hldgs %
12.15%
Holding
3,986
New
247
Increased
2,455
Reduced
1,098
Closed
86
Avg Time Held
4.1
years
Top 10 Avg Time Held
3.3
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.17B |
| 2 |
Apple
AAPL
|
+$849M |
| 3 |
Chevron
CVX
|
+$746M |
| 4 |
Synopsys
SNPS
|
+$643M |
| 5 |
Wells Fargo
WFC
|
+$633M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$517M |
| 2 |
Booking.com
BKNG
|
+$488M |
| 3 |
Walmart Inc
WMT
|
+$414M |
| 4 |
Sandisk
SNDK
|
+$355M |
| 5 |
Cigna
CI
|
+$325M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.5% |
| 2 | Financials | 14.38% |
| 3 | Industrials | 14.21% |
| 4 | Consumer Discretionary | 10.53% |
| 5 | Healthcare | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3101
Main Sector Rotation ETF
SECT
$2.76B
| $841K | ﹤0.01% |
11,664
-320
| -3% | -$21.8K |
2025 Q2
4 quarters
|
|
3102
National Presto Industries
NPK
$1.02B
| $840K | ﹤0.01% |
6,722
-505
| -7% | -$68.5K |
2020 Q2
24 quarters
|
|
3103
Aquestive Therapeutics
AQST
$454M
| $840K | ﹤0.01% |
201,941
+150,347
| +291% | +$633K |
2024 Q3
7 quarters
|
|
3104
Putnam Focused Large Cap Value ETF
PVAL
$15.2B
| $840K | ﹤0.01% |
16,480
-2,979
| -15% | -$148K |
2025 Q3
3 quarters
|
|
3105
LSI Industries
LYTS
$642M
| $836K | ﹤0.01% |
31,454
-24,178
| -43% | -$559K |
2023 Q4
10 quarters
|
|
3106
VanEck Fabless Semiconductor ETF
SMHX
$219M
| $835K | ﹤0.01% |
+13,067
| New | +$718K |
2026 Q2
0 quarters
|
|
3107
State Street SPDR S&P Homebuilders ETF
XHB
$1.57B
| $833K | ﹤0.01% |
7,210
+4,356
| +153% | +$456K |
2025 Q4
2 quarters
|
|
3108
Goldman Sachs Equal Weight US Large Cap Equity ETF
GSEW
$2.14B
| $832K | ﹤0.01% |
8,809
-865
| -9% | -$78.7K |
2025 Q2
4 quarters
|
|
3109
Precigen
PGEN
$1.6B
| $830K | ﹤0.01% |
145,600
-39,394
| -21% | -$170K |
2024 Q1
9 quarters
|
|
3110
Eagle Financial Services Inc
EFSI
$247M
| $829K | ﹤0.01% |
20,001
+8,894
| +80% | +$348K |
2025 Q3
3 quarters
|
|
3111
Liberty Capital Corp Series A GCI Group Common Stock
GLIBA
$1.05B
| $828K | ﹤0.01% |
37,825
+30,090
| +389% | +$851K |
2025 Q4
2 quarters
|
|
3112
Alliance Laundry Holdings
ALH
$4.49B
| $827K | ﹤0.01% |
31,167
+16,022
| +106% | +$400K |
2026 Q1
1 quarter
|
|
3113
Kestra Medical Technologies
KMTS
$1.72B
| $825K | ﹤0.01% |
+32,447
| New | +$679K |
2026 Q2
0 quarters
|
|
3114
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.92B
| $825K | ﹤0.01% |
29,584
+17,761
| +150% | +$507K |
2025 Q4
2 quarters
|
|
3115
Vanguard Industrials ETF
VIS
$7.82B
| $824K | ﹤0.01% |
2,287
-1,233
| -35% | -$418K |
2025 Q2
4 quarters
|
|
3116
FS Bancorp
FSBW
$343M
| $822K | ﹤0.01% |
18,951
+6,560
| +53% | +$269K |
2025 Q2
4 quarters
|
|
3117
Astrana Health
ASTH
$1.71B
| $818K | ﹤0.01% |
17,628
-16,751
| -49% | -$603K |
2025 Q3
3 quarters
|
|
3118
iShares MSCI World ETF
URTH
$8.81B
| $817K | ﹤0.01% |
+4,032
| New | +$798K |
2026 Q2
0 quarters
|
|
3119
FT Vest US Equity Moderate Buffer ETF March
GMAR
$421M
| $817K | ﹤0.01% |
18,460
| – | – |
2025 Q2
4 quarters
|
|
3120
Distillate US Fundamental Stability & Value ETF
DSTL
$2.14B
| $817K | ﹤0.01% |
13,632
+738
| +6% | +$43.7K |
2026 Q1
1 quarter
|
|
3121
Greene County Bancorp
GCBC
$615M
| $816K | ﹤0.01% |
24,288
+7,723
| +47% | +$199K |
2025 Q2
4 quarters
|
|
3122
Carriage Services
CSV
$426M
| $815K | ﹤0.01% |
21,244
+10,162
| +92% | +$445K |
2020 Q2
24 quarters
|
|
3123
DELISTED
Theravance Biopharma
TBPH
| $813K | ﹤0.01% |
47,820
+20,463
| +75% | +$339K |
2025 Q1
5 quarters
|
|
3124
Maze Therapeutics
MAZE
$1.9B
| $810K | ﹤0.01% |
27,161
-784
| -3% | -$20.5K |
2025 Q2
4 quarters
|
|
3125
Genco Shipping & Trading
GNK
$1.13B
| $810K | ﹤0.01% |
32,679
-27,723
| -46% | -$669K |
2020 Q4
22 quarters
|
|
Similar funds
Cliff Asness's Q2 2026 Portfolio in Review
As of Q2 2026, Cliff Asness held 3,986 positions worth $287B, up 31% from $218B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Cliff Asness deployed $37.5B of net new capital in Q2 2026, opening 247 new positions and adding to 2,455 existing holdings. Its largest new stake was FedEx Freight: 1,024,555 shares worth $155M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Micron Technology, an estimated $517M trimmed.
- Cliff Asness's largest Q2 2026 buy was FedEx Freight: 1,024,555 shares worth $155M.
- Cliff Asness added most to NVIDIA in Q2 2026, an estimated $1.17B increase.
- Cliff Asness's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $517M.
- Cliff Asness fully exited Masimo in Q2 2026, selling an estimated $147M.
- Cliff Asness's ten largest holdings make up 12% of its $287B portfolio in Q2 2026.
- Cliff Asness opened 247 new positions and closed 86 in Q2 2026.
- Cliff Asness's portfolio value rose 31% quarter-over-quarter to $287B.
Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.